当前位置:主页 > 医学论文 > 妇产科论文 >

寿胎丸加味联合地屈孕酮治疗早期先兆流产合并SCH的临床研究

发布时间:2018-04-03 22:34

  本文选题:寿胎丸加味 切入点:早期先兆流产 出处:《山东中医药大学》2017年硕士论文


【摘要】:目的:观察寿胎丸加味联合地屈孕酮治疗早期先兆流产合并绒毛膜下血肿(Subchorionic hematoma,SCH)的临床疗效,为更好的治疗早期先兆流产合并SCH提供新思路及临床依据。方法:纳入62例患者,均符合早期先兆流产合并SCH,中医证型为肾虚血热型的诊断标准。将纳入的患者随机分为试验组和对照组各31例,试验组给予寿胎丸加味联合地屈孕酮治疗,对照组给予地屈孕酮治疗,连续用药2周。观察两组SCH面积、SCH面积/孕囊面积以及中医证候积分的变化情况。结果:试验组的总有效率为90.32%,对照组总有效率67.74%,两者比较差异有统计学意义(P0.05);试验组在改善中医证候积分、减少阴道流血时间以及减小血肿方面均优于对照组,差异均具有统计学意义(P0.05)。治疗观察期间,试验组及对照组均未见不良反应。结论:寿胎丸加味联合地屈孕酮能够有效的改善早期先兆流产合并SCH患者的中医临床症状,减小SCH以及减少阴道流血时间。运用寿胎丸加味联合地屈孕酮治疗早期先兆流产合并SCH值得在临床上进一步应用与研究。
[Abstract]:Methods: 62 cases of early threatened abortion combined with SCH were included, and the TCM syndrome type was kidney deficiency and blood fever.The patients were randomly divided into trial group (n = 31) and control group (n = 31). The experimental group was treated with Shou-Feiwan plus Diproprogesterone, while the control group was treated with diproprogesterone for 2 weeks.The changes of SCH area / gestational sac area and TCM syndrome score were observed.Results: the total effective rate of the test group was 90.32 and the total effective rate of the control group was 67.74.The difference between the two groups was statistically significant (P 0.05), and the experimental group was superior to the control group in improving the score of TCM syndromes, reducing the vaginal bleeding time and reducing the hematoma.The difference was statistically significant (P 0.05).No adverse reactions were observed in both the experimental group and the control group during the treatment period.Conclusion: modified Shou-Tye Pill combined with Diproprogesterone can effectively improve the clinical symptoms of early threatened abortion with SCH, reduce SCH and reduce vaginal bleeding time.The treatment of early threatened abortion with SCH with modified Shou-Tye Pill and Diflexiplesterone is worthy of further clinical application and study.
【学位授予单位】:山东中医药大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R714.21

【参考文献】

相关期刊论文 前10条

1 李晓彬;郭义红;;超声检测低分子肝素联合免疫球蛋白治疗绒毛膜下血肿的疗效和妊娠结局的临床价值[J];临床和实验医学杂志;2017年08期

2 张阳;;间苯三酚联合HCG及地屈孕酮治疗先兆流产合并绒毛膜下血肿患者60例临床观察[J];当代医学;2017年10期

3 杨慧;崔海峰;;补肾健脾活血法治疗早期先兆流产合并绒毛膜下血肿临床研究[J];临床医药文献电子杂志;2016年31期

4 代良敏;熊永爱;范奎;林影影;杨明;;地榆化学成分与药理作用研究进展[J];中国实验方剂学杂志;2016年20期

5 王素霞;;滋肾育胎丸治疗中孕早期先兆流产合并绒毛膜下出血的临床研究[J];河北医学;2016年05期

6 方芳;胡丽莎;陈晓勇;明章书;;寿胎丸加减方联合地屈孕酮治疗早期先兆流产合并绒毛膜下血肿临床研究[J];时珍国医国药;2016年04期

7 郑勇凤;王佳婧;傅超美;王建新;;黄芩的化学成分与药理作用研究进展[J];中成药;2016年01期

8 岳洁;刘晓华;卢钺;高海侠;申英;吴海英;;早孕期绒毛膜下血肿的位置与大小对妊娠结局的影响[J];中国妇幼保健;2015年34期

9 言齐;黄文瑾;王峰;郭伟娣;;早孕先兆流产合并绒毛膜下血肿的妊娠结局研究[J];中国医药科学;2015年20期

10 刘昱磊;王俊玲;刘新玉;滕辉;;罗颂平教授治疗先兆流产合并绒毛膜下血肿经验[J];环球中医药;2015年07期



本文编号:1707194

资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/fuchankeerkelunwen/1707194.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户06c4b***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com